[ad_1]
As countries rush to get immunization in the arms of their people, one country dominates the rest of the field: Israel.
According to data collected by Our World in Data, Israel administered the COVID vaccine at a per capita rate of nearly 25 per 100 people. This equates to just over 23% of the population having received at least one dose of vaccine.
Rule the world
Americans have watched with horror as many state governments have mismanaged the administration of the COVID vaccine. Most notably, New York, thanks to Democratic Governor Andrew Cuomo’s disastrous deployment plan, has seen healthcare facilities forced to reject expired doses.
Although only about 3% of the U.S. population has received the vaccine, not all states have been a disaster, as West Virginia, South Dakota, and North Dakota lead the way with high rates of vaccination per capita above average.
But Israel has somehow avoided such catastrophes and made even the most prosperous states in the United States look like failures in comparison.
And they leave the rest of the world in the dust.
In less than a month, the country has vaccinated nearly a quarter of its population. It distributes injections to nearly 150,000 people every day, Vox reported, and although the country has created a priority list, it has made it a practice from the start to make sure doses are not wasted. In fact, the nation was so successful that the concern was running out of doses, but the administration of Prime Minister Benjamin Netanyahu struck a deal with Pfizer.
From Vox:
In recent weeks, the country has fired around 150,000 people a day. Priority went to people over 60 and health workers; however, in order to avoid wasting injections that could spoil, other Israelis were given the vaccine if they knew the right clinic or were in the right place at the right time.
Israel’s rapid campaign worked almost too well: the country quickly began to run out of doses, threatening to slow the pace of new vaccinations. Israel also pledged to reserve a second dose for anyone who received the first. Follow-up appointments are scheduled 21 days after the first shot, often until the exact day, sometimes on time.
But on January 7, Israeli Prime Minister Benjamin Netanyahu announced that the country had reached a deal with Pfizer to deliver more vaccines, with the goal of vaccinating all citizens over the age of 16 by the end of March. . With more than 70% of people over 60 already vaccinated, Netanyahu said on Sunday that the campaign would soon be expanded to include all people 50 and over, and would strive to get 170,000 vaccinations every day.
Israel secured the Pfizer deal by agreeing to share with the company and the World Health Organization the age, gender and medical history of all those vaccinated, as well as how well the vaccinations work and any side effects. , Politico reported.
So how is the rest of the world doing? Well, not great.
The United Arab Emirates comes in second, with a percent rate of 15.45. The third is Bahrain with 6.44. And it only gets worse from there.
And there is still a lot of work to be done as a percentage of the population for every nation – even Israel.
(H / T: HotAir)
window.REBELMOUSE_LOWEST_TASKS_QUEUE.push(function(){
window.REBELMOUSE_STDLIB.loadExternalScript("https://cdn.optimizely.com/js/8667924112.js", function() {
});
});
window.REBELMOUSE_LOWEST_TASKS_QUEUE.push(function(){
window.REBELMOUSE_STDLIB.loadExternalScript("https://cdn.sendpulse.com/js/push/c1cf05cedec34f81a01419e313027a78_1.js", function() {
});
});
window.REBELMOUSE_LOWEST_TASKS_QUEUE.push(function(){
window.REBELMOUSE_STDLIB.loadExternalScript("https://cdn.sendpulse.com/sp-push-worker-fb.js?ver=2.0%27", function() {
console.log ('sendpulse loaded');
});
});
window.REBELMOUSE_LOWEST_TASKS_QUEUE.push(function(){
//Facebook Pixel Code !function(f,b,e,v,n,t,s) {if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}; if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0'; n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0]; s.parentNode.insertBefore(t,s)}(window, document,'script', 'https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1398069580413568'); fbq('track', 'PageView');
});
window.REBELMOUSE_LOWEST_TASKS_QUEUE.push(function(){
window.REBELMOUSE_STDLIB.loadExternalScript("https://ak.sail-horizon.com/spm/spm.v1.min.js", function() {
Sailthru.init({ customerId: 'ec5d4cf4c3fb97d6cf3b6b487843b55d' });
});
});
window.REBELMOUSE_LOWEST_TASKS_QUEUE.push(function(){
window.REBELMOUSE_STDLIB.loadExternalScript("https://assets.revcontent.com/master/delivery.js", function() {
});
});
window.REBELMOUSE_LOWEST_TASKS_QUEUE.push(function(){
function menuClick() { console.log("clicked");
if (document.querySelector('.hambg-btn.js--active') != null) { document.getElementsByClassName('huge-menu')[0].style.display = 'none'; document.getElementsByClassName('hambg-btn')[0].classList.remove('js--active'); document.body.classList.remove("huge-menu-opened"); document.body.classList.remove("menu-opened"); } else{ document.getElementsByClassName('huge-menu')[0].style.display = 'block'; document.getElementsByClassName('hambg-btn')[0].classList.add('js--active'); document.body.classList.add("huge-menu-opened"); document.body.classList.remove("menu-opened"); } }
function searchClick() { console.log("search clicked");
if (document.querySelector('.search-opened') != null) { document.body.classList.remove("search-opened"); } else { document.body.classList.add("search-opened"); } }
function addMenuClickListener() { var rebelMenu = document.getElementsByClassName('rebelbar__menu-toggle'); var menuClose = document.getElementsByClassName('hm__close'); var stickyMenu = document.getElementsByClassName('sticky-menu'); var searchEnable = document.getElementsByClassName('search-custom-icon'); var searchSticky = document.getElementsByClassName('search-icon-sticky'); var searchClose = document.getElementsByClassName('search-close');
rebelMenu[0].addEventListener('click', menuClick);
if(menuClose[0] != undefined){ menuClose[0].addEventListener('click', menuClick);}
if(stickyMenu[0] != undefined){ stickyMenu[0].addEventListener('click', menuClick); }
if(searchEnable[0] != undefined){ searchEnable[0].addEventListener('click', searchClick); }
if(searchSticky[0] != undefined){ searchSticky[0].addEventListener('click', searchClick); }
if(searchClose[0] != undefined){ searchClose[0].addEventListener('click', searchClick); } }
addMenuClickListener();
});
window.REBELMOUSE_LOWEST_TASKS_QUEUE.push(function(){
function test_adblock(func, id) { var t="0.1.2-dev", el = document.createElement('div'); el.id = id ? id : 'sponsorText'; el.appendChild(document.createTextNode(' ')); Object.assign(el.style, { left: '-999px', position: 'absolute' }); document.body.appendChild(el); setTimeout(function() { if (el) { var o = el.clientHeight === 0; func(o, t); document.body.removeChild(el); } }, 200); } test_adblock(function(is_blocked) { console.log(is_blocked); var wid = is_blocked ? 140286 : 140117, target = document.getElementById('rc-adblock-widget'); var el = document.createElement('div'); el.setAttribute('data-rc-widget', ''); el.setAttribute('data-endpoint', 'trends.revcontent.com'); el.setAttribute('data-widget-id', wid); target.appendChild(el); if (typeof window.renderRCWidget !== 'function') { var script = document.createElement('script'); script.src="https://assets.revcontent.com/master/delivery.js"; script.defer = true; target.appendChild(script); } else { window.renderRCWidget(el) } });
});
window.REBELMOUSE_LOWEST_TASKS_QUEUE.push(function(){
(function(s,u,m,o,j,v){j=u.createElement(m);v=u.getElementsByTagName(m)[0];j.async=1;j.src=o;j.dataset.sumoSiteId='f20bb26e74a94a53daa9113206b98941e1dfba90635d317b9efd9e33a89bf515';v.parentNode.insertBefore(j,v)})(window,document,'script','//load.sumo.com/');
});
[ad_2]
Source link